KKR:NYSEKKR & Co. Inc. Analysis
Data as of 2026-03-10 - not real-time
$90.94
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
KKR is trading at $90.94, well below its 20‑day SMA of 97.50 and the 50‑day SMA of 113.03, with the price sitting just above the computed support level of $84.52. The RSI of 35.5 signals that the stock is approaching oversold territory, while the MACD histogram has turned positive, indicating a tentative bullish reversal despite a broader bearish trend and a high 30‑day volatility of 57.4%. The equity carries a beta of 1.85, suggesting amplified moves relative to the market, and the fear‑greed index is at “Extreme Greed,” reflecting strong investor appetite despite the recent 23% price decline over the past month.
Fundamentally, KKR posted an impressive 76% revenue growth year‑over‑year, with operating margins above 33% and a solid cash pile of $42.6 bn, though it also holds $56.0 bn of debt. The current PE of 38.9 is far above the industry average of 17.4, but the forward PE of 11.45 and a mean analyst target of $140.35 point to significant upside (≈54%). Recent news highlights a strong Q4 2025 earnings beat, a director’s $4.7 m share purchase, and rumors of a multibillion‑dollar exit from CoolIT Systems, all of which bolster the “buy‑the‑dip” narrative from Wall Street analysts.
Fundamentally, KKR posted an impressive 76% revenue growth year‑over‑year, with operating margins above 33% and a solid cash pile of $42.6 bn, though it also holds $56.0 bn of debt. The current PE of 38.9 is far above the industry average of 17.4, but the forward PE of 11.45 and a mean analyst target of $140.35 point to significant upside (≈54%). Recent news highlights a strong Q4 2025 earnings beat, a director’s $4.7 m share purchase, and rumors of a multibillion‑dollar exit from CoolIT Systems, all of which bolster the “buy‑the‑dip” narrative from Wall Street analysts.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above technical support
- Bearish SMA alignment and high short‑term volatility
- Oversold RSI suggesting limited further downside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE of 11.45 indicating cheap valuation relative to earnings growth
- Analyst consensus (19 analysts) rating the stock as a buy with a $136‑$140 target
- Potential multibillion‑dollar exit from CoolIT providing a catalyst
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong cash generation and diversified global asset base
- Sustainable dividend yield with a low payout ratio
- Continued strategic acquisitions and exits driving long‑term earnings expansion
Key Metrics & Analysis
Financial Health
Revenue Growth76.30%
Profit Margin9.24%
P/E Ratio38.9
ROE8.56%
ROA1.60%
Debt/Equity68.61
P/B Ratio2.9
Op. Cash Flow$477.8M
Industry P/E17.4
Technical Analysis
TrendBearish
RSI35.5
Support$84.52
Resistance$109.53
MA 20$97.50
MA 50$113.03
MA 200$126.92
MACDBullish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Target Price$140.35
Upside/Downside54.33%
GradeUndervalued
TypeGrowth
Dividend Yield0.81%
Risk Assessment
Beta1.85
Volatility57.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.